Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00006361
First received: October 4, 2000
Last updated: December 3, 2009
Last verified: December 2002
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2003 (Final data collection date for primary outcome measure)
Publications:
Zahalsky AJ, Wong RJ, Lis E, et al.: Phase II trial of SU5416 in patients with advanced incurable head and neck cancer. [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-902, 2002.